A “Better Than Bitcoin” Biotech Bet

With several exciting product candidates in its pipeline that could achieve blockbuster status, the author of today’s article believes that the clinical-stage biotech that he highlights, which is focused on developing treatments for disorders that affect the central nervous system, is a better bet than an investment that’s all the rage these days: bitcoin. For the biotech in question and an overview of its leading pipeline candidates, CLICK HERE.